📊 DBV's FDA BLA Looms

Good Morning Investors,

Policy and geopolitical developments also remain in focus. Ongoing discussions around AI regulation, export controls, and access to advanced models have the potential to reshape competitive positioning across technology markets. These policy shifts can create both opportunities and risks depending on where they sit within the AI supply chain.

Today’s session reinforces that market leadership remains highly concentrated. Semiconductors, AI infrastructure, and catalyst driven biotech continue to outperform, but the lack of broader participation suggests investors should remain selective until market breadth begins to improve.

Matthias Schneider
Editor at Analytica Investor